INVITATION Patient Seminar:  Improving Survival in Multiple Myeloma Dr. Henry Chan from North Shore Hospital will be speaking at our patient seminar...
News
Daratumumab approved for use on NHS in Scotland
Patients in Scotland will now be able to access the new myeloma treatment, daratumumab (Darzalex®) on the NHS, after the Scottish Medicines...
Article of the Week: Delineation of the timing of second-line therapy post–autologous stem cell transplant in patients with AL amyloidosis
For this week's Article of the Week, we look at an article that describes a review of patient data from the Mayo Clinic. The study sought to...
Article of the week: Genetic changes associated with the evolution of Monoclonal Gammopathy of Unknown Significance (MGUS)
For this week's Article of the Week we have chosen a review article published in the British Journal of Haematology co-authored by MSAG member Dr...
Article of the week: Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease
For this week's Article of the Week we have chosen an article which is particularly relevant to the results of the recent VCAT study which is...
Article of the week: The use of sclerostin to increase bone mass and reduce the incidence of fractures in multiple myeloma
For this week's Article of the Week relates to a presentation made by Petere Croucher on the osteocyte-specific protein sclerostin at the most...
Article of the week: Letters to Blood – Panobinostat induces CD38 upregulation and augments the antimyeloma efficacy of daratumumab
GarcÃa-Guerrero et al described their laboratory study where myeloma cells from 12 patients were treated with titrated doses of panobinostat (0, 10...
Article of the week: Phase 1b study of isatuximab plus lenalidomide and dexamethasone
A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma'Â is a study intended to assess the...
Article of the week: The role of serum IgM levels as a predictor of symptomatic hyperviscosity in Waldenström’s macroglobulinaemia (WM)
This week's Article of the Week is a study that was recently published in the British Journal of Haematology on the role of serum IgM levels as a...
Drugs for incurable blood cancer ‘should be available’
About 400 New Zealanders a year are diagnosed with the blood cancer multiple myeloma, and the number is rising. A malignancy of the plasma cell, it...
Article of the week: Monoclonal antibody therapy in multiple myeloma
This review discusses pre-clinical and clinical studies on the use of monoclonal antibodies in multiple myeloma, including agents which have been...
Launch
On November 22, Â 2016 Â in Wellington a group of New Zealand based hematology specialists led by Kenneth Romeril launched a new initiative for...